Chromenone-based GSK-3ß inhibitors as potential therapeutic targets for cardiovascular diseases: In silico study, molecular dynamics, and ADMET profiles
Glycogen synthase kinase-3 beta (GSK-3ß) regulates glycogen metabolism and many different cellulars, including apoptosis, signaling, and neural. It is a crucial therapeutic receptor in heart disease, type 2 diabetes, and Alzheimer’s. In this study, using computational methods, flavonoid compounds we...
Saved in:
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English English |
Published: |
Elsevier B.V.
2022
|
Subjects: | |
Online Access: | https://eprints.ums.edu.my/id/eprint/35099/1/ABSTRACT.pdf https://eprints.ums.edu.my/id/eprint/35099/2/FULL%20TEXT.pdf https://eprints.ums.edu.my/id/eprint/35099/ https://www.sciencedirect.com/science/article/pii/S1878535222006049 https://doi.org/10.1016/j.arabjc.2022.104288 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|